Mr Daniel Kaufman

Biography

Professor in Molecular and Medical Pharmacology. Professor Kaufman's research is focused on GAD and its relation to diabetes. In a research paper in November 1993, Professor Kaufman demonstrated that the administration of GAD to mice that would otherwise develop type 1 diabetes prevented the outbreak of this disorder. Professor Kaufman was the first to clone a GAD gene and his lab was the first to demonstrate that a GAD treatment could inhibit diabetes in mice with established autoimmune responses. Professor Kaufman was a member of the group associated with Professor Allan J. Tobin, which was the first to submit a patent application for the full cDNA code for GAD, the patent portfolio that Diamyd Medical licenses. Professor Kaufman has been a member of the Scientific and Medical Advisory Board since 1996.

Research Interest

Molecular Pharmacology, Medical Pharmacology, Medicine etc